1. Home
  2. Analysis
  3. Lipitor
  4. Chronic-gastrointestinal-bleeding

Lipitor and Chronic gastrointestinal bleeding - a phase IV clinical study of FDA data

Summary:

Chronic gastrointestinal bleeding is reported as a side effect among people who take Lipitor (atorvastatin calcium), especially for people who are female, 60+ old, also take Lantus, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Chronic gastrointestinal bleeding when taking Lipitor. It is created by eHealthMe based on reports of 251,142 people who have side effects when taking Lipitor from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Chronic gastrointestinal bleeding?

Chronic gastrointestinal bleeding is found to be associated with 52 drugs and 125 conditions by eHealthMe. Check the latest studies of Chronic gastrointestinal bleeding.

On Jul, 28, 2026

251,142 people reported to have side effects when taking Lipitor.
Among them, 11 people (0.0%) have Chronic gastrointestinal bleeding.

Could Lipitor cause Chronic gastrointestinal bleeding?

Among these 11 people:

What is the gender of people who have Chronic gastrointestinal bleeding when taking Lipitor? *

  • female: 54.55 %
  • male: 45.45 %

What is the age of people who have Chronic gastrointestinal bleeding when taking Lipitor? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Lipitor? *

  1. Lantus: 7 people, 63.64%
  2. Lasix: 4 people, 36.36%
  3. Tricor: 3 people, 27.27%
  4. Xarelto: 3 people, 27.27%
  5. Synthroid: 3 people, 27.27%
  6. Protonix: 3 people, 27.27%
  7. Flonase: 3 people, 27.27%
  8. Xyzal: 2 people, 18.18%
  9. Pradaxa: 2 people, 18.18%
  10. Kenalog: 2 people, 18.18%

What are other side effects people have besides Chronic gastrointestinal bleeding? *

  1. Nosebleed (bleeding from nose): 3 people, 27.27%
  2. Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 2 people, 18.18%
  3. Adverse Event: 2 people, 18.18%
  4. Anaemia (lack of blood): 2 people, 18.18%
  5. Appendicitis (inflammation of the appendix): 2 people, 18.18%
  6. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 18.18%
  7. Blood Iron Decreased: 2 people, 18.18%
  8. Iron Deficiency Anaemia: 2 people, 18.18%
  9. Abdominal Discomfort: 2 people, 18.18%
  10. Renal Disorder (kidney disease): 2 people, 18.18%

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 45.45%
  2. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 18.18%
  3. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 2 people, 18.18%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 18.18%
  5. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 18.18%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 18.18%
  7. Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 18.18%
  8. Diabetes: 2 people, 18.18%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 18.18%
  10. B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and have Chronic gastrointestinal bleeding?

- Check whether Chronic gastrointestinal bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lipitor:

Chronic gastrointestinal bleeding treatments and more:

How severe was Chronic gastrointestinal bleeding and when was it recovered:

Expand to all the drugs that have ingredients of atorvastatin calcium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic gastrointestinal bleeding:

Browse all the conditions that are associated with Chronic gastrointestinal bleeding:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Lipitor) and Lipitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.